Becker & Poliakoff assisted Shenzhen Qianzhi BioTech Company Limited (“Qianzhi BioTech”), a Cayman Islands exempted company, in the negotiation, structuring, and documentation of a definitive Business Combination Agreement for a business combination with Bowen Acquisition Corp. (NASDAQ: BOWN) (“BOWN”). The Becker corporate team served as a U.S. legal advisor and […]
Becker is proud to announce the successful closing of a business combination between its SPAC client, Mana Capital Acquisition Corp. (“Mana Capital”), and Cardio Diagnostics, Inc. (“Cardio”), a pioneering precision cardiovascular medicine company at the intersection of epigenetics and artificial intelligence whose products enable improved prevention, early detection and treatment...
Becker Shareholder Jie Chengying Xiu attended the International Leadership Foundation’s (“ILF”) three-day meeting and annual Gala Award event from July 27 to July 29 in Washington, D.C. Jie is a member of the ILF’s national advisory board. The gala award event is one of the most prominent events for Asian-American […]
On July 19, Becker Shareholder, Jie Chengying Xiu spoke as one of the panelists at the Asian Financial Society’s panel, “Can Chinese Companies Continue To Be Listed In the US.” The topics she discussed included the new SEC rules and regulations on China-related SPACs, the challenges and opportunities facing Chinese companies […]
Becker Shareholders Jie Chengying Xiu, Brian Daughney, and Michael Goldstein of the firm’s New York office represented client EF Hutton as the undrwriter counsel in connection with Technology & Telecommunication Acquisition Corporation, in connection with the company’s initial public offering, which closed on January 20, 2022. EF Hutton, division of […]
